acetaminophen 325 MG Oral Tablet [Cetafen]
- RxCUI
- 1358837
- RxNorm name
- acetaminophen 325 MG Oral Tablet [Cetafen]
- Display name
- CETAFEN (Oral Pill)
- Full name
- acetaminophen 325 MG Oral Tablet [Cetafen]
- Term type
- SBD
- Status
- Active
- Strength
- 325 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-17 23:55:23
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122012
- Active start
- 122012
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| acetaminophen | 325 MG / 1 EACH | acetaminophen | acetaminophen |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| acetaminophen | 161 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Cetafen 325 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | acetaminophen 325 MG Oral Tablet [Cetafen] | 1 | NAMES |
| RxNorm Synonym | 2 linked values | 2 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | c1162bab-377d-4e17-9417-ccd20d29148b | 1 | CODES |
| RxCUI | 1358837 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 50332-0148-1 | 50332-0148 | CETAFEN ACETAMINOPHEN | HART Health | M |
| 50332-0148-4 | 50332-0148 | CETAFEN ACETAMINOPHEN | HART Health | M |
| 50332-0148-7 | 50332-0148 | CETAFEN ACETAMINOPHEN | HART Health | M |
| 50332-0148-8 | 50332-0148 | CETAFEN ACETAMINOPHEN | HART Health | M |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| M | 50332-0148 | CETAFEN ACETAMINOPHEN | OTC MONOGRAPH DRUG | HART Health |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CETAFEN | ACETAMINOPHEN | HART Health | c1162bab-377d-4e17-9417-ccd20d29148b | 2025-12-24 | Warnings | 50332-0148-7 50332-0148-4 50332-0148-8 50332-0148-1 50332-0148 50332014804 50332014808 50332014801 50332014807 1358837 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3a18f784-429a-40c9-ac38-685c7d1f4752 | Cetafen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG Oral Tablet [Cetafen] [SBD] · APAP 325 MG Oral Tablet [Cetafen] [SY] · Cetafen 325 MG Oral Tablet [SY] | 4 | 8 | CETAFEN | 20230811 |
| c1162bab-377d-4e17-9417-ccd20d29148b | Cetafen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG Oral Tablet [Cetafen] [SBD] · APAP 325 MG Oral Tablet [Cetafen] [SY] · Cetafen 325 MG Oral Tablet [SY] | 4 | 4 | CETAFEN | 20251224 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| c1162bab-377d-4e17-9417-ccd20d29148b | CETAFEN | HART Health | 20251224 |
| 3a18f784-429a-40c9-ac38-685c7d1f4752 | CETAFEN | HART Health | 20230811 |
| e012d671-4769-4164-930f-001422d02e22 | CETAFEN | A-S Medication Solutions | 20180815 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N02BE | Anilides | ATC1-4 | acetaminophen | |
| MEDRT | D000082 | Acetaminophen | CHEM | has_ingredient | acetaminophen |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | acetaminophen |
| MEDRT | D005334 | Fever | DISEASE | may_prevent | acetaminophen |
| MEDRT | D005334 | Fever | DISEASE | may_treat | acetaminophen |
| MEDRT | D005955 | Glucosephosphate Dehydrogenase Deficiency | DISEASE | ci_with | acetaminophen |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_treat | acetaminophen |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | acetaminophen |
| MEDRT | N0000175724 | Central Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | acetaminophen |
| MEDRT | N0000009072 | Hypothalamic Endocrine Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000175725 | Peripheral Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | acetaminophen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | acetaminophen |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 325 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Prescribable Synonym | Cetafen 325 MG Oral Tablet |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |